Medical Device Clinical Registries
Registry strategy, design, and execution that turns real-world device data into regulatory and commercial evidence.
What Is a Clinical Registry, and Why Does It Matter?
What Is a Clinical Registry, and Why Does It Matter?
A clinical registry is an organized system for collecting uniform, real-world data on how a device performs across patients over time. For medical device and IVD manufacturers, registries increasingly determine market access: regulators, payers, and internal evidence strategies all draw on the same underlying data, and a poorly designed registry can slow approvals as easily as a well-designed one accelerates them.
As a full-service medical device CRO for clinical registries, our team of regulatory and clinical strategy experts helps you design, implement, and optimize registries that meet regulatory, payer, and scientific expectations. From protocol design and ethics submission to site selection, data management, and analysis, we support your device lifecycle end-to-end so you can generate reliable real-world evidence with speed and compliance.
How a Clinical Registry Differs From a PMCF Study
The two terms get used interchangeably, but they're not the same thing. A PMCF study is a manufacturer-run, protocol-driven study built around one specific device, conducted to satisfy the post-market clinical follow-up obligation in MDR Annex XIV, Part B. A registry is broader: it's one of the two specific methods Annex XIV, Part B names for fulfilling that obligation, alongside a dedicated PMCF study, but registries also exist independently of any single manufacturer's MDR obligation, often spanning multiple products, indications, or even a whole national specialty, a national joint registry, for example. A "PMCF registry" is simply a registry built or used to meet that specific regulatory purpose.
Our Clinical Registries Services:
Registry Strategy & Planning
We assess your device portfolio, regulatory requirements, and commercial objectives to design a registry strategy that balances evidence needs, operational feasibility, and stakeholder expectations. This includes defining endpoints, population, comparator arms, and data collection scope.
Protocol Development & Regulatory Alignment
Our experts draft scientifically rigorous protocols aligned with regulatory guidance (e.g., MDR, FDA, NICE) and payer expectations. We support ethics submissions, informed consent development, and alignment with national or regional registry standards.
Site Selection & Data Capture
We coordinate site identification, contracting, and investigator engagement to ensure efficient patient recruitment and high-quality data capture. Our team supports electronic data capture (EDC) systems, case report form design, and compliance with GCP and local regulations.
Data Analysis & Reporting
We provide statistical analysis planning, interim monitoring, and final registry reports. These outputs can support regulatory submissions, Health Technology Assessments (HTAs), and publications.
Post-market evidence & continuous improvement
We help you leverage registry data for post-market surveillance, trend detection, and iterative improvement. This ensures ongoing compliance, regulatory readiness, and evidence-based commercial insights.
Why Clinical Registries Matter Across the Device Lifecycle
Why Clinical Registries Matter Across the Device Lifecycle
Registries keep devices safe, effective, and valuable throughout their lifecycle, across seven distinct purposes:
1. Patient safety (post-market surveillance)
- Detects rare or long-term adverse events that may not appear in clinical trials
- Monitors device performance in real-world use
- Enables early identification of safety signals and device failures
2. Clinical effectiveness
- Evaluates how well a device works in everyday clinical practice
- Compares outcomes across patient groups, indications, or techniques
- Helps refine clinical guidelines and best practices
3. Regulatory and compliance purposes
- Supports regulatory requirements (e.g., FDA post-market surveillance, EU MDR post-market clinical follow-up)
- Provides evidence for continued market approval or label expansion
- Demonstrates ongoing benefit–risk assessment
4. Quality improvement
- Identifies variability in device use and outcomes across centers
- Supports benchmarking between hospitals or clinicians
- Drives improvements in training, device design, and care pathways
5. Health economics and reimbursement
- Generates real-world evidence on cost-effectiveness
- Supports payer and reimbursement decisions
- Helps justify adoption of new or innovative devices
6. Innovation and lifecycle management
- Informs future device development and design improvements
- Supports next-generation devices and accessories
- Helps manufacturers understand real-world usage patterns
7. Research and knowledge generation
- Enables observational research and hypothesis generation
- Complements randomized controlled trials
- Provides data for publications and scientific collaboration
Ineffective registry planning, such as unclear endpoints or insufficient data quality controls, can result in incomplete data, regulatory pushback, market access delays, and wasted operational resources.
We apply a structured, audit-grade methodology from protocol design to reporting, aligned with your strategic goals. Through careful planning, proactive site engagement, robust data management, and compliance oversight, we help your registry deliver actionable evidence efficiently and reliably.
Ineffective registry planning, such as unclear endpoints or insufficient data quality controls, can result in incomplete data, regulatory pushback, market access delays, and wasted operational resources.
We apply a structured, audit-grade methodology from protocol design to reporting, aligned with your strategic goals. Through careful planning, proactive site engagement, robust data management, and compliance oversight, we help your registry deliver actionable evidence efficiently and reliably.
Still have questions? We are here to help, including with clinical strategy support.
Are registries mandatory?
Some registries are required by regulators or payers, while others are voluntary but strategically valuable for demonstrating real-world effectiveness, safety, and comparative performance.
How long does a registry typically take?
Timelines depend on registry scope, patient population, and regulatory requirements. Programs can range from months (small observational studies) to multiple years (multi-country, long-term follow-up).
What are the risks of poor registry execution?
Risks include incomplete or unreliable data, delayed regulatory submissions, operational inefficiency, and inability to demonstrate device value to stakeholders.
Relevant Blogs
Qserve guides manufacturers with regulatory expertise, Notified Body selection, CE compliance support and strategic insights for faster approval.
Discover what to consider for a right system, and how implementing an eTMF can make your clinical trials more efficient, organized, and inspection ready
Meet Iris Verboven, Business Operation Mangaer at Qserve CRO, whose practical approach ensures the best-fit solutions for your clinical trials.